Seabound vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 60)

Seabound

ChallengerClimate & Energy

General

Maritime carbon capture startup using calcium oxide chemistry to capture ship exhaust CO2 as solid calcium carbonate for offloading; onboard retrofit technology for shipping decarbonization.

AI VisibilityBeta
Overall Score
B60
Category Rank
#175 of 1167
AI Consensus
63%
Trend
stable
Per Platform
ChatGPT
61
Perplexity
57
Gemini
55

About

Seabound is a maritime carbon capture technology company developing systems that capture CO2 from ship exhaust directly onboard vessels, storing it as calcium carbonate for offloading at port — enabling the shipping industry to reduce emissions without switching to alternative fuels. Founded in 2021 and headquartered in London, Seabound has raised approximately $4.8 million in seed funding and is developing a post-combustion carbon capture approach that can retrofit onto existing ships without requiring engine replacements or fuel changes.\n\nSeabound's system works by diverting flue gas from a ship's engine exhaust through a reaction chamber containing calcium oxide (quicklime), which reacts with CO2 to form calcium carbonate — a solid, stable material that can be offloaded at port and sold as a feedstock for construction materials or industrial processes. This chemistry eliminates the need for compressed CO2 storage or cryogenic liquefaction, which are significant technical and safety challenges for onboard carbon capture. The calcium oxide can be regenerated at port facilities.\n\nIn 2025, Seabound operates in the emerging maritime decarbonization market where the International Maritime Organization (IMO) has established targets to cut shipping emissions 50% by 2050. Maritime shipping is responsible for approximately 2.5% of global CO2 emissions, and the sector faces growing regulatory pressure (EU ETS carbon pricing extending to shipping from 2024). Seabound competes with other maritime carbon capture startups and against alternative decarbonization approaches (ammonia fuel, hydrogen, LNG). The 2025 strategy focuses on completing pilot installations on commercial vessels, demonstrating the techno-economic case for operators, and partnering with port infrastructure providers for calcium oxide supply and calcium carbonate offtake.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

60
Overall Score
90
#175
Category Rank
#9
63
AI Consensus
60
stable
Trend
stable
61
ChatGPT
99
57
Perplexity
99
55
Gemini
83
61
Claude
96
71
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.